![Elizabeth Hanna](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 334 079 $ in data 30/09/2026
Elizabeth S.
Hanna is currently an Independent Director at Treace Medical Concepts, Inc. since 2021.
Formerly, Ms. Hanna was Chief Commercial Officer & Executive VP at Agendia, Inc. from 2022 to 2023.
From 2019 to 2022, served as President, Chief Executive Officer & Director at Clinical Genomics, Inc. From 2014 to 2018, held the roles of President & Chief Executive Officer at ShiftWise, Inc. and President & Chief Operating Officer at Origin Life Sciences, Inc. Between 2012 and 2014, was Vice President-Global Strategic Marketing and Member-Global Management Board at Johnson & Johnson and Johnson & Johnson Vision Care, Inc., respectively.
Education includes undergraduate studies at the University of Illinois and an MBA from Harvard Business School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 19/05/2026 | 75.243 ( 0,12% ) | 334 079 $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. | Direttore/Membro del Consiglio | 01/10/2021 |
| Società | Posizione | Fine |
|---|---|---|
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Provides genomics technologies for clinical management of cancer | Corporate Officer/Principal | 01/09/2023 |
Clinical Genomics, Inc.
 Clinical Genomics, Inc. Medical/Nursing ServicesHealth Services Provides genomic screening services | Amministratore Delegato | 01/03/2022 |
ShiftWise, Inc.
 ShiftWise, Inc. Miscellaneous Commercial ServicesCommercial Services Provides web-based systems to manage and procure supplemental medical staff | Amministratore Delegato | 01/09/2018 |
Origin Life Sciences, Inc.
 Origin Life Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops plasma devices to generate nitric oxide | Presidente | 01/01/2018 |
| JOHNSON & JOHNSON | Vendite & Marketing | 01/04/2014 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 9 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
ShiftWise, Inc.
ShiftWise, Inc. Miscellaneous Commercial ServicesCommercial Services Provides web-based systems to manage and procure supplemental medical staff | Commercial Services |
Origin Life Sciences, Inc.
Origin Life Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops plasma devices to generate nitric oxide | Health Technology |
Treace Medical Concepts, Inc.
 Treace Medical Concepts, Inc. Medical SpecialtiesHealth Technology Manufactures and sells orthopedic medical devices | Health Technology |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnson & Johnson Vision Care, Inc.
 Johnson & Johnson Vision Care, Inc. Electronic ComponentsElectronic Technology Manufactures and markets vision care products | Electronic Technology |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Provides genomics technologies for clinical management of cancer | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clinical Genomics, Inc.
Clinical Genomics, Inc. Medical/Nursing ServicesHealth Services Provides genomic screening services | Health Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
